Development of new therapy for children suffering from Epidermolysis Bullosa

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Skin blistering diseases affect 1:17,000 live births. Constant skin blistering affects the quality of life and is often fatal in the first 2 years. For those children that survive, skin blistering leads to scarring, fusion of the fingers, infections and skin cancers. To date, the management of blistered children is mainly supportive and no specific cure exists. This study will develop new therapies for children with skin blistering diseases and will significantly improve their quality of life.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2015

Funding Scheme: Early Career Fellowships

Funding Amount: $307,946.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Dermatology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cell adhesion | cell migration | fibrosis | skin | wound healing